<code id='BF3BC63173'></code><style id='BF3BC63173'></style>
    • <acronym id='BF3BC63173'></acronym>
      <center id='BF3BC63173'><center id='BF3BC63173'><tfoot id='BF3BC63173'></tfoot></center><abbr id='BF3BC63173'><dir id='BF3BC63173'><tfoot id='BF3BC63173'></tfoot><noframes id='BF3BC63173'>

    • <optgroup id='BF3BC63173'><strike id='BF3BC63173'><sup id='BF3BC63173'></sup></strike><code id='BF3BC63173'></code></optgroup>
        1. <b id='BF3BC63173'><label id='BF3BC63173'><select id='BF3BC63173'><dt id='BF3BC63173'><span id='BF3BC63173'></span></dt></select></label></b><u id='BF3BC63173'></u>
          <i id='BF3BC63173'><strike id='BF3BC63173'><tt id='BF3BC63173'><pre id='BF3BC63173'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:9
          Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT
          Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

          WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

          The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

          advertisement

          The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          JPM pitch from hospitals? Revenue streams outside of patient care

          AdobeSANFRANCISCO—IfyoulearnedanythingaboutnonprofithospitalsonthefirstdayoftheJ.P.MorganHealthcareC